48,830
edits
(→Classification: more) |
|||
Line 119: | Line 119: | ||
====Classification==== | ====Classification==== | ||
Classification based on extent:<ref name=pmid21252716>{{cite journal |author=Travis WD, Brambilla E, Noguchi M, ''et al.'' |title=International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma |journal=J Thorac Oncol |volume=6 |issue=2 |pages=244–85 |year=2011 |month=February |pmid=21252716 |doi=10.1097/JTO.0b013e318206a221 |url=}}</ref> | |||
#Adenocarcinoma in situ (AIS) - previously known as [[BAC]]. | |||
*Minimally invasive adenocarcinoma (MIA). | #*Subtypes: nonmucinous, mucinous, mixed mucinous/nonmucinous. | ||
* | #Minimally invasive adenocarcinoma (MIA). | ||
* | #*Lepidic growth with upto 5 mm of invasion. | ||
#*Subtypes: nonmucinous (most common), mucinous, mixed mucinous/nonmucinous. | |||
#Invasive adenocarcinoma: | |||
* | #*Subtypes: micropapillary, mucinous (previously ''mucinous BAC'', colloid, fetal, enteric. | ||
==Neuroendocrine tumours== | ==Neuroendocrine tumours== |
edits